Salubris

002294

29.650.44% ( -0.13 )

Delay Closed: Nov 13, 15:00:00

Current ValuationThe current P/E ratio is 46.23, within the reasonable range, cheaper than 60.99% of the time in the past 10 years, and the industry ranks 98/222, the industry Median 22.14.

46.23xP/E

Stock price¥29.65Earnings per share¥0.64

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

Industry median 22.14x

015304560

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

Industry median 22.14x

0x40x80x120x160x200x

P/E ratio
Name/Symbol
600436SHZZPZH	59.74x	17.36%	¥78.67B
002653SZHaisco	50.79x	572.55%	¥66.21B
002821SZAsymchem	45.04x	16.47%	¥53.35B
300765SZCSPC Innovation	48.61x	628.47%	¥48.26B
002294SZSalubris	46.23x	29.31%	¥33.05B
300199SZHYBIO	50.09x	--	¥20.13B
301569SZNOVAST	51.54x	--	¥16.04B
603858SHBUCHANG PHARMA	54.82x	--	¥15.45B
002626SZKingdomway	44.37x	26.67%	¥10.33B
600851SHHX GROUP	53.47x	--	¥10.21B
300725SZPHARMABLOCK	45.80x	18.18%	¥10.15B
600789SHLKPC	52.76x	--	¥7.19B
688553SHHUIYU PHARMACEUTICAL	51.95x	--	¥6.71B
688799SHHWPC	54.63x	24.46%	¥6.22B
301393SZHighfine	46.92x	--	¥5.79B
002390SZxinbang phar.	41.16x	--	¥5.70B
002907SZPharscin Pharma	57.86x	--	¥5.43B
002940SZALK	42.97x	--	¥4.74B
301281SZKeyuan Pharma	59.12x	--	¥4.16B
300584SZHicin Pharmaceutical	50.17x	--	¥3.59B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.